相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma
Hailong Ma et al.
BRITISH JOURNAL OF CANCER (2018)
Oral cancer-derived exosomal NAP1 enhances cytotoxicity of natural killer cells via the IRF-3 pathway
Yingnan Wang et al.
ORAL ONCOLOGY (2018)
Head and Neck Carcinoma Immunotherapy: Facts and Hopes
Theresa L. Whiteside
CLINICAL CANCER RESEARCH (2018)
Targeting adenosine in cancer immunotherapy: a review of recent progress
Theresa L. Whiteside
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma
Hai-long Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma
Manuela Silginer et al.
NEURO-ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Type I Interferon in Chronic Virus Infection and Cancer
Laura M. Snell et al.
TRENDS IN IMMUNOLOGY (2017)
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
Marco Ruella et al.
CANCER DISCOVERY (2017)
Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using PatientDerived Xenografts
Shuyang Sun et al.
THERANOSTICS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
Hailong Ma et al.
JOURNAL OF CANCER (2017)
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients
Guillermo De Velasco et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Kanstantsin V. Katlinski et al.
CANCER CELL (2017)
Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes
Cherie T. Ng et al.
CELL (2016)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
IL-17A Exacerbates Fibrosis by Promoting the Proinflammatory and Profibrotic Function of Orbital Fibroblasts in TAO
Sijie Fang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Overexpression of stathmin/oncoprotein 18 correlates with poorer prognosis and interacts with p53 in oral squamous cell carcinoma
Hai-Long Ma et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2016)
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
Francesco Sabbatino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma
Francesco Sabbatino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
Chuan Liu et al.
EMBO MOLECULAR MEDICINE (2015)
XL413, a cell division cycle 7 kinase inhibitor enhanced the anti-fibrotic effect of pirfenidone on TGF-β1-stimulated C3H10T1/2 cells via Smad2/4
Shu-fang Jin et al.
EXPERIMENTAL CELL RESEARCH (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue
Stephanie Booy et al.
PANCREAS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Netanya G. Sandler et al.
NATURE (2014)
IFNAR1 Is a Predictor for Overall Survival in Colorectal Cancer and Its mRNA Expression Correlated With IRF7 But Not TLR9
Liang-Che Chang et al.
MEDICINE (2014)
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
Doron Levin et al.
SCIENCE SIGNALING (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway
Jiao Chen et al.
IMMUNOBIOLOGY (2012)
Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation
Jacob Piehler et al.
IMMUNOLOGICAL REVIEWS (2012)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity
Seigo Terawaki et al.
JOURNAL OF IMMUNOLOGY (2011)
A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell Carcinoma
Chien-Hua Peng et al.
PLOS ONE (2011)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity
Paola Rizza et al.
AUTOIMMUNITY (2010)
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
Cherry L. Estilo et al.
BMC CANCER (2009)
Critical role for constitutive type I interferon signaling in the prevention of cellular transformation
Hui-min Chen et al.
CANCER SCIENCE (2009)
IFN-α wakes up sleeping hematopoietic stem cells
Emmanuelle Passegue et al.
NATURE MEDICINE (2009)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Selection and validation of differentially expressed genes in head and neck cancer
MA Kuriakose et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis
A Cromer et al.
ONCOGENE (2004)
Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck
MA Ginos et al.
CANCER RESEARCH (2004)
Type I interferon differential therapy for erythroleukemia: specificity of STAT activation
VS Cull et al.
BLOOD (2003)
The restricted expression of granzyme M in human lymphocytes
TJ Sayers et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
